РусскийEnglish (UK)
     
 

Публикации с 2016 года

Кол-во строк: 
# Заголовок
51 Macrophages and Their Contribution to the Development of Atherosclerosis.

Bobryshev YV1,2,3, Nikiforov NG4,5, Elizova NV4,5, Orekhov AN4,5,6,7.

Results Probl Cell Differ. 2017;62:273-298. doi: 10.1007/978-3-319-54090-0_11.

52 Chemokines and Relevant microRNAs in the Atherogenic Process.

Chistiakov DA1, Orekhov AN2, Bobryshev YV3.

Mini Rev Med Chem. 2017 Apr 19. doi: 10.2174/1389557517666170419113211. [Epub ahead of print]

53 Nanocarriers in improving chemotherapy of multidrug resistant tumors: Key developments and perspective.

Chistiakov DA1, Myasoedova VA2, Orekhov AN3, Bobryshev YV4.

Curr Pharm Des. 2017 Apr 7. doi: 10.2174/1381612823666170407123941. [Epub ahead of print]

54 Editorial: Conventional, Traditional and Alternative Therapies for Cardiovascular Disorders.

55 Cell-Based Models for Development of Antiatherosclerotic Therapies.

Zakiev ER, Nikiforov NG, Orekhov AN.
Biomed Res Int. 2017;2017:5198723. doi: 10.1155/2017/5198723. Epub 2017 Feb 14.

56 Analysis of Apolipoprotein B Protein of Circulating Multiple-Modified Low-Density Lipoprotein.

Zakiev ER, Sukhorukov VN, Ivanova EA, Orekhov AN.

Int J Angiol. 2017 Mar;26(1):49-52. doi: 10.1055/s-0036-1588062. Epub 2016 Dec 26.

57 Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of patients' Blood: Development of Therapeutic Approaches to reduce blood Atherogenicity.

Nikiforov NG, Zakiev ER, Elizova NV, Sukhorukov VN, Orekhov AN.

Curr Pharm Des. 2017 Jan 24. [Epub ahead of print]

58 The phenomenon of atherosclerosis reversal and regression: Lessons from animal models.

Chistiakov DA, Myasoedova VA, Revin VV, Orekhov AN, Bobryshev YV.

Exp Mol Pathol. 2017 Feb;102(1):138-145. doi: 10.1016/j.yexmp.2017.01.013. Epub 2017 Jan 17.

59 Use of Primary Macrophages for Searching Novel Immunocorrectors.

Nikiforov NG, Elizova NV, Bukrinsky M, Dubrovsky L, Makeev VJ, Wakabayashi Y, Liu P, Foxx KK, Kruth HS, Jin X, Zakiev ER, Orekhov AN.

Curr Pharm Des. 2017 Jan 25. [Epub ahead of print]

60 Blood Serum Atherogenicity: Cellular Test for the Development of Anti-Atherosclerotic Therapy.

Myasoedova VA, Ivashinnikova GA, Sobenin IA, Ivanova EA, Orekhov AN.
Curr Pharm Des. 2017 Jan 2. [Epub ahead of print]